These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26740820)

  • 21. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.
    Rodríguez AE; Robledo C; García JL; González M; Gutiérrez NC; Hernández JA; Sandoval V; García de Coca A; Recio I; Risueño A; Martín-Núñez G; García E; Fisac R; Conde J; de Las Rivas J; Hernández JM
    Ann Oncol; 2012 Aug; 23(8):2138-2146. PubMed ID: 22228453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma.
    Daudignon A; Poulain S; Morel P; Penther D; Parmentier F; Bouchindhomme B; Fernandes J; Duthilleul P; Bastard C
    Leuk Res; 2010 May; 34(5):580-4. PubMed ID: 19959229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines.
    Lia M; Carette A; Tang H; Shen Q; Mo T; Bhagat G; Dalla-Favera R; Klein U
    Blood; 2012 Mar; 119(13):2981-90. PubMed ID: 22174151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
    Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
    Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia.
    Starostik P; O'Brien S; Chung CY; Haidar M; Manshouri T; Kantarjian H; Freireich E; Keating M; Albitar M
    Leuk Res; 1999 Sep; 23(9):795-801. PubMed ID: 10475618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene dosage effects in chronic lymphocytic leukemia.
    Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
    Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Yeung CC; Powers ML; Nguyen TD; Kreisel F; Frater JL; Zehnbauer BA; Burack R; Hassan A
    Int J Surg Pathol; 2011 Oct; 19(5):563-9. PubMed ID: 21536543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
    Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
    Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 level as a biomarker for 13q14 deletion in CLL.
    Degheidy HA; Gadalla SM; Farooqui MZ; Abbasi F; Arthur DC; Bauer SR; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
    Cytometry B Clin Cytom; 2013; 84(4):237-47. PubMed ID: 23674504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
    Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
    Hogan WJ; Tefferi A; Borell TJ; Jenkins R; Li CY; Witzig TE
    Cancer Genet Cytogenet; 1999 Apr; 110(2):77-81. PubMed ID: 10214353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
    Durak Aras B; Isik S; Uskudar Teke H; Aslan A; Yavasoglu F; Gulbas Z; Demirkan F; Ozen H; Cilingir O; Inci NS; Gunden G; Bulduk T; Erzurumluoglu Gokalp E; Kocagil S; Artan S; Akay OM
    Mol Cytogenet; 2021 Jan; 14(1):2. PubMed ID: 33407772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
    McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Spencer Leal E; Faulkner CL; Palmer A; Wragg C; Jefferies S; Brandner S; Vale L; Higgins JP; Kurian KM
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013387. PubMed ID: 35233774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies.
    Chena C; Avalos JS; Bezares RF; Arrossagaray G; Turdó K; Bistmans A; Slavutsky I
    Eur J Haematol; 2008 Aug; 81(2):94-9. PubMed ID: 18462257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.